Home
Conditions
Histiocytosis, Langerhans-Cell

Clinical trial condition

Histiocytosis, Langerhans-Cell

Explore clinical trials studying Histiocytosis, Langerhans-Cell. Study availability and eligibility vary by location and protocol.

62 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis, Langerhans-Cell trial results

Completed

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

NCT01395004

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

Staten Island University Hospital Staten Island, New York, United States

View Trial Details

Completed

Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

NCT00048373

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

NCT02665546

Conditions: Cardiovascular Diseases, Dyspnea, Hemic and Lymphatic Diseases, +14 more
Locations: InCor Heart Institute São Paulo, Brazil

View Trial Details

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

NCT02608619

Conditions: Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, +8 more
Locations: Memoral Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Stem Cell Transplant for Immunologic or Histiocytic Disorders

NCT00176865

Conditions: Albinism, Chediak-Higashi Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations: Masonic Cancer Center University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

NCT01471067

Conditions: Blood And Marrow Transplantation, Bone Marrow Diseases, Chromosome Aberrations, +38 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function

NCT01651507

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Saint Louis hospital Paris, France

View Trial Details

Completed

Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis

NCT01225601

Conditions: Adult Pulmonary Langerhans Cell Histiocytosis, Hemic and Lymphatic Diseases, Histiocytosis, +5 more
Locations: Hôpital Saint Louis Paris, France

View Trial Details

Completed

Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

NCT00588536

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Histiocytosis, Langerhans-Cell

Histiocytosis, Langerhans-Cell trial results

Related conditions